Qualigen Therapeutics, Inc.

F3-8-60 inhibits RAS RAF interaction and blocks RAS Signaling

F3-8-60 inhibits RAS RAF interaction and blocks RAS Signaling

Format

PNG

Quelle:

Qualigen Therapeutics, Inc.

Downloads